In the tumor microenvironment, the activated PD-1/B7-H1 (programmed cell death 1/PD-L1) signaling pathway makes T lymphocytes functionally inactivated [2,5], which decreases the anti-tumor activity of T cells. This evidence concerns the gene PDCD1 and neoplasm.